Houwing, Danielle J.de Waard, JolienRamsteijn, Anouschka S.Woelders, Tomde Boer, Sietse F.Wams, Emma J.Olivier, Jocelien D.A.2021-03-292021-03-292020-08Houwing, D J, de Waard, J, Ramsteijn, A S, Woelders, T, de Boer, S F, Wams, E J & Olivier, J D A 2020, 'Perinatal fluoxetine exposure disrupts the circadian response to a phase-shifting challenge in female rats', Psychopharmacology, vol. 237, no. 8, pp. 2555-2568. https://doi.org/10.1007/s00213-020-05556-20033-3158ORCID: /0000-0002-7269-1707/work/91892353https://hdl.handle.net/2164/16144Funding Information: This research was funded by the Dobberke foundation, grant number UPS/BP/4151 2016-27.14846442engSDG 3 - Good Health and Well-being5-HT1A receptorAnxietyCircadian behaviorClock genesCoping styleFluoxetineHypothermiaPerinatalPregnancyRC0321 Neuroscience. Biological psychiatry. NeuropsychiatryPharmacologyRC0321Perinatal fluoxetine exposure disrupts the circadian response to a phase-shifting challenge in female ratsJournal article10.1007/s00213-020-05556-2http://www.scopus.com/inward/record.url?scp=85086428495&partnerID=8YFLogxK2378